Bionaut Labs
Los Angeles
About Bionaut Labs
Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality. By creating a new medical modality of remote-controlled micro-robots called Bionauts, the company can transform the way the biopharmaceutical industry develops treatments, allowing them to engineer the therapeutic index for efficacy and maintain safety. Bionaut Labs is focused on helping patients suffering from debilitating brain diseases who have few available treatment options. The anatomical targeting capabilities of the Bionaut platform make new therapeutics technologies such as gene therapy, CRISPR-Cas9, and oncolytic viruses viable in challenging clinical settings.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $63.2M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2024)
- Website: bionautlabs.com
- Phone: (425) 269-6252
Industries & Categories
Biopharma, Biotechnology, Health Care, Precision Medicine, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bionaut-labs-22662 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.